Fresenius Medical Care AG & Co. KGaA, 3M and Medtronic are Dominating the Canada Hemodialysis and Peritoneal Dialysis Market in 2019

Global Hemodialysis and Peritoneal Dialysis Market is expected to grow with the CAGR of 5.3% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access full Report @https://www.databridgemarketresearch.com/reports/canada-hemodialysis-and-peritoneal-dialysis-market

Canada hemodialysis and peritoneal dialysis market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Canada hemodialysis and peritoneal dialysis market are introducing strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition, agreement, business expansion, award and recognition into the hemodialysis and peritoneal dialysis market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in February 2019, Fresenius Medical Care AG & Co. KGaA acquired NxStage Medical, a company focuses on manufacturing and supply of dialysis products across various regions of the world. This acquisition helped the company to broaden its product portfolio for dialysis, which led to earn more economic benefit.

Fresenius Medical Care AG & Co. KGaA is the dominating player in Canada hemodialysis and peritoneal dialysis market. The other key players existing in the market includes BD, 3M, Medionics, Dialco Medical Inc, Newsol Technologies Inc., CardioMed Supplies Inc. (a subsidiary of NIPRO), Baxter, Cantel Medical, Medtronic and AngioDynamics among others. 

Canada Hemodialysis And Peritoneal Dialysis MarketFresenius Medical Care AG & Co. KGaA:

Fresenius Medical Care AG & Co. KGaA headquartered in Bad Homburg, Germany was founded in 1996. The company is focused on providing products and services for people having chronic kidney failure. The company has wide product portfolio such as dialysis products & therapies and renal pharmaceuticals in which dialysis products & therapies is the market focused category.

For instance,

  • In June 2019, Fresenius Medical Care AG & Co. KGaA opened up a new laboratory in Mississippi, North America in order to conduct analysis and testing of newly developed products. This expansion helped the company to advance up the developmental procedure of new products.

The company has wide presence across Africa, Asia-Pacific, Europe, Middle East and Americas. The company also has various subsidiary companies such as NxStage (U.S.), Xenios AG (Germany), Renal Research Institute, LLC (U.S.), National Medical Care, Inc. (U.S.), Fresenius Medical Center Inc (Germany) among others.

3M:

3M headquartered in Minnesota, U.S. was founded in 1902. The company is engaged in manufacturing of products using advanced science in order to improve daily lives of the people. The company operates in business through multiple segments such as safety and industrial business, transportation and electronics business, health care business and consumer business in which health care business is market focused segment. The company has wide product portfolio including automotive, commercial solutions, design & construction, electronics, energy, government, health care, manufacturing, mining, oil & gas, safety and transportation in which health care is the market focused category.

For instance,

  • In March 2015, 3M completed the acquisition of Ivera Medical Corp. This acquisition has helped the company to broaden its vascular access solutions to provide more health care facilities worldwide.

The company has presence across Americas, Europe, Middle East & Africa and Asia-Pacific. The company also has various subsidiary companies such as 3M Unitek Corporation (U.S.), 3M Australia Pty. Ltd (Australia), 3M Precision Grinding GmbH (Austria), 3M International Trading (Shanghai) Co., Ltd (China), 3M Deutschland GmbH (Germany) among others.

Medtronic:

Medtronic headquartered in Dublin, Ireland was founded in 1949. The company is engaged in contributing to human health by application of biomedical engineering in the research, design, manufacture, and sale of instruments and appliances that alleviate pain and extend life. The company operates its business through multiple business segments which are cardiac and vascular group, minimally invasive therapies group, restorative therapies group and diabetes group in which restorative therapies group is the market focused segment. The company is engaged in providing wide range of product categories such as advanced surgical technology, cardiac rhythm, cardiovascular, diabetes, digestive & gastrointestinal, ear, nose & throat, general surgery, gynecological, neurological, oral maxillofacial & dental, patient monitoring, renal care, respiratory, spinal & orthopaedic, surgical navigation & imaging and urological in which renal care is the market focused product category.

For instance,

  • In May 2017, Medtronic started clinical trial of IN.PACT(TM) AV Access Drug-Coated Balloon (DCB) in patients suffering from end stage renal disease. As the number of patients undergoing dialysis has increased in Canada, this product approval through clinical trial enhanced the company’s product portfolio of dialysis.

The company has wide presence in North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. The company has several owned subsidiaries involving Medtronic Bio-Medicus, Inc. (U.S.), Medtronic China, Ltd. (U.S.), Medtronic Comercial Ltd. (Brazil), Medtronic Endonetics, Inc. (U.S.) and Medtronic G.m.b.H. (Germany) among others.